Skip to main content
. 2003 Jul 21;2003(3):CD003293. doi: 10.1002/14651858.CD003293

Borden 1987.

Methods RCT
Participants 361 randomized
 275 evaluable
Interventions Dox q 3 weeks
Dox weekly
Dox + DTIC
Outcomes Response
 Survival
 Toxicity
 PFI
Notes Two single‐agent doxorubicin arms included
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment (selection bias) Low risk A ‐ Adequate